NEWSLETTER

Sign up to read weekly email newsletter
Asia Tech Times
Donate
Search
  • Home
  • Breaking News
  • Business
  • Finance
  • Medical
  • Political
Reading: Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down
Share
Font ResizerAa
Asia Tech TimesAsia Tech Times
  • Finance
  • Technology
Search
  • Home
  • Categories
    • Finance
    • Technology
  • More Foxiz
    • Blog Index
    • Forums
    • Complaint
    • Sitemap
Follow US
Made by ThemeRuby using the Foxiz theme. Powered by WordPress
Medical

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

By Asia Tech Times
Last updated: 16/05/2025
2 Min Read
Share

People use weight loss pills, such as Ozempic and Wegovy to drink less alcohol



People use weight loss pills, such as Ozempic and Wegovy to drink less alcohol

00:19

Novo Nordisk, a pharmaceutical company of Blockbuster Wegovy maker Novo Nordisk, said Friday that its CEO is resigning with the company’s board of directors, citing “recent market challenges” and a sharp decline.

Lars Fruergaard Jorgensen’s departure has lowered its sales and profit forecasts and has dropped more than 50% as the company’s stock has fallen by more than 50% since mid-2024.

Wegovy sales in the United States have been cut, the company said on May 7 Cheaper replicas Production by so-called composite pharmacies using active ingredients of patented drugs. When there is no name branded drugs, they are relied on as alternatives. However, the FDA said the shortage has eased and replicas will be stopped in the coming months.

People have lost weight using Wegovy rival Zepbound, made by Wegovy rival Eli Lilly, a study published in the New England Journal of Medicine on Sunday. Eli Lilly funded the study. Novo Nordisk’s share price fell 54% from its June 2024 peak. Its listed shares fell another 3% in listing trading on Friday.

The company, based in Denmark-based Bagsvaerd, praised Jorgensen for leading Novo Nordisk to Novo Nordisk during his eight-year tenure as CEO.

“However, given the recent market challenges Novo Novers faces and the changes in the company’s share price development since mid-2024,” the company said in a statement. The board and Jorgensen “conclude together that it is in the best interest of the company and its shareholders to initiate the CEO succession.”

Jorgensen will continue to serve as CEO for a period of time to support a smooth transition.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Email Copy Link Print

SUBSCRIBE NOW

Subscribe to our newsletter to get our newest articles instantly!

HOT NEWS

Singapore-Based Fintech Unicorn Airwallex Elevates $300 Million

Jack Zhang, founder and chief executive officer of Airwallex. Given by Airwallex h Worldwide repayment…

17/07/2025

China’s CATL Really feels the Pinch of a Lithium Cost Downturn it Developed

Years of long-lasting decreases in lithium costs are currently beginning to take a toll on…

19/03/2025

OpenAI strategies Sora video clip generator combination right into ChatGPT

Sora was released in December 2024 as a standalone internet application, making it possible for…

19/03/2025

YOU MAY ALSO LIKE

Nonetheless, high membership and licensing expenses position difficulties to development.

Nonetheless, high membership and licensing costs position a development obstacle.

Medical
14/07/2025

What aspects drive the Asia Pacific’s Gaucher condition therapy market?

By 2034, the market is anticipated to get to $553.8 million. According to Polaris Marketing Research, the expanding assimilation of…

Medical
11/07/2025

McCrae Hospitals and FV Healthcare facility companion to breakthrough electronic person portal

Sign Up With the Health Care Asia Publication Area. Given That you’re below … … You can advertise your firm…

Medical
11/07/2025

The state of abortion, 3 years after Roe v. Wade was reversed

Abortion condition, Roev. Wade was toppled 3 years after it was toppled – CBS Information / Enjoy CBS Information It…

Medical
06/07/2025

Asia Tech Times (ISSN: 3079-8566) stands as a preeminent authority in technology journalism, delivering profound insights and strategic intelligence on the technological advancements shaping the Asia-Pacific region and beyond. Renowned for its depth of analysis and editorial excellence, the publication serves as a critical nexus for industry leaders, policymakers, scholars, and innovators navigating the evolving digital landscape.

  • Jobs Board
  • About Us
  • Contact Us
  • Privacy Policy
  • Exclusives
  • Learn How
  • Support
  • Solutions
  • Terms And Conditions
  • Editorial Policy
  • Marketing Solutions
  • Industry Intelligence

Follow US: 

Copyright © 2025 Asia Tech Times. All Rights Reserved.

All content published by Asia Tech Times (ISSN: 3079-8566), including but not limited to articles, reports, editorials, graphics, images, logos, and digital media, is the exclusive intellectual property of Asia Tech Times and is protected under international copyright laws and treaties.

Asia Tech TimesAsia Tech Times
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?